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T cells play an essential role in the process of recovery from primary infection of mice 
with ectromelia virus, a poxvirus related to vaccinia and variola viruses (1-4), but the 
precise mechanisms involved and the participation of different effector T-cell subsets and 
ancillary cells remain to be fully elucidated. Massive liver necrosis is the major cause of 
death (1-3). Recovery therefore depends upon control of virus replication  and spread in 
progressing lesions of  the liver parenchyma and upon control of  infection in other tissues, 
such as spleen, which may contribute to the cell-associated viremia (1) which in turn may 
initiate new liver lesions. 
A number of potential mechanisms of recovery could be supplied by effector T cells. 
First, cytotoxic T cells could kill virus-infected cells before they support virus replication, 
thus halting virus spread; this is feasible since ectromelia-infected cells display antigenic 
changes recognized by cytotoxic T  cells  long before progeny  virus is  assembled  (5). 
Second, recognition of foci of infection by effector T cells leads to recruitment (2, 3, 6) and 
activation (7)  of mononuclear  phagocytes  which  destroy  virus-infected  material  (3). 
Third, effector T cells may secrete interferon at sites of infection, thus protecting other 
cells in the immediate vicinity (3, 8).  Available  evidence denies an important role for 
helper T cells and antibody in the normal process of recovery (1-4). 
All of the mechanisms described above would require specific recognition of 
virus-induced antigenic patterns, since the protection conferred by immune T 
cells  is  virus specific (2). However,  recent findings in a  number of different 
systems indicate that cytotoxic T cells do not simply recognize virus-specified 
antigenic determinants, but that host cell gene(s) in the H-2 gene complex are 
involved in producing new antigenic patterns on infected cells (9-14). Thus, T- 
cell-mediated lysis of ectromelia-infected target cells requires H-2K-  or H-2D- 
region homology between donors of cytotoxic T cells and infected target cells 
(15). Previous experiments with inbred mice have also shown that transfer of 
virus clearance mechanisms triggered by effector T  cells  against ectromelia 
infection in vivo is not possible unless one H-2 haplotype is shared by donors ofT 
cells  and  virus-infected recipients  (4). Since  the  antiviral  effect is  seen  in 
recipients within 24 h of cell transfer and since F1 hybrid-parental strain donor- 
recipient combinations are effective, it seems that failure to transfer the effect to 
totally aUogeneic recipients is not due to rejection of the transferred T cells, but 
to failure of T cells to recognize virus-induced antigenic patterns on allogeneic 
cells  (4). We describe here  a  series  of cell transfer experiments,  using mice 
bearing recombinant or mutant H-2 haplotypes, which further define the H-2 
requirement. 
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Materials and Methods 
Animals.  All mouse strains were bred at the John Curtin School and used at 7-10 wk of age. 
Virus.  Virulent (Moscow) and attenuated (Hampstead egg) strains of ectromelia virus were 
grown (1) and titrated by plaque assay on L929 cells as described previously (1, 4). 
Immunization and Cell Transfer Procedures.  Donors of immune spleen cells were immunized 
intravenously (i.v.) with 2 x  104 plaque-forming units (PFU) of attenuated virus, and their spleens 
were harvested 5 days later at about the peak of the effector T-cell response 1 (2). Cell suspensions 
(4) were transferred i.v.  to recipients that had been infected i.v.  24 h  previously with virulent 
virus. Antiviral effects transferred were determined by titrating virus in individual spleens (and 
sometimes livers) of groups of four recipients sacrificed 24 h  after cell transfer (2, 4). Data from 
spleen and liver are essentially similar (2), but spleens are more conveniently titrated and spleen 
data only are given here. Statistical significance was determined by Student's t tests. 
Results and Discussion 
Transfer of antiviral activity occurred only in donor-recipient combinations 
which shared either K-  or D-region genes (Table I).  /-region homology was 
neither sufficient nor necessary, and the remainder of the genotype seemed 
irrelevant. These results thus conform with previous data indicating a require- 
ment for K- or D-region genes in expression of T-cell-mediated lysis of virus- 
infected or TNP-modified target cells in vitro (15, 16). Cytetoxic T  cells may 
therefore play a  central  role  in  recovery, particularly since  the  kinetics of 
production in the spleen of T cells with in vivo antiviral function (as described 
here) and in vitro cytotoxicity are similar. ~  However, this evidence is indirect, 
and a firm conclusion cannot yet be drawn. 
Since/-region homology between donors and recipients is sufficient for other 
T-cell functions such as helper activity (17), delayed-type hypersensitivity to 
nonviral antigens (18), and protection against bacterial infection,  2 the present 
data indicate that the effector T cells responsible for virus clearance, whatever 
the mechanisms they employ or trigger, are a  subset that is defined by the 
requirement for operation of gene(s) in the K orD regions of  the H-2 complex. 
The molecular basis for the phenomena cited above (9-16)  poses important 
questions. Let us assume that immunocompetent, precursor T cells employ the 
same mechanisms of antigen recognition while interacting with infected "stimu- 
lator" cells during the process of induction of the effector T-cell response, as 
employed by their progeny (effector T cells) which lyse infected target cells in 
vitro or trigger virus clearance in vivo. Potential models for these interactions 
have been proposed  and tested by Zinkernagel and  Doherty (19). Available 
evidence from experiments with lymphocytic  choriomeningitis (LCM) virus (19, 
20), ectromelia virus, 3  trinitrophenyl (TNP)-modified cells (16), and minor histo- 
compatibility antigens (12) supports the following model. T cells interact with 
stimulater or target cells only via receptors for antigen, but the major antigenic 
patterns recognized are not simply virus specified; they incorporate features 
dictated by K- or D- region genes. This raises questions concerning the way in 
i  Blanden, R. V., and I. D. Gardner. Manuscript in  preparation. 
2  Dunlop, M. B. C., U. Kees, and R. V. Blanden. Unpublished data. 
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TABLE  I 
H-2 Requirement for Transfer* of Antiviral Effect by Ectromelia-Immune  T Cells 
Expt. 
Immune T-cell  donors  Virus tAters in recipient spleens 24 h after cell transfer 
Strain  H-2 maps  Strain  H-2 maps  TAter§ 
BALB/c  dddddd  BALB/c  dddddd  <1.30 I{ 
C3H.OH  dddddk  BALB/c  dddddd  < 1.30 I[ 
D2.GD  ddbbbb  BALB/c  dddddd  < 1.30  II 
B10.A(2R)  kkkddb  BALB/c  dddddd  5.11  ± 0.13 
A.TFR 2  ffffsd  BALB/c  dddddd  1.46 _+ 0.24 II 
Nil  BALB/c  dddddd  5.12  ±  0.11 
CBA/H  kkkkkk  A.TL  skkkkd  4.60  _+ 0.35 
SJL/J  ssssss  A.TL  ~Id:l=kd  < 1.30  II 
BALB/c  dddddd  A.  TL  skkkkd  < 1.30  I[ 
Nil  A.TL  skkkkd  4.89  ± 0.94 
CBA/H  kkkkkk  CBA/H  kkkkkk  <1.30 I1 
Nil  CBA/H  kkkkkk  5.07  ±  0.30 
Hzl  "ba"bbbbb  Hzl  "ba"bbbbb  3.32  ±  0.56 II 
B10.A(SR)  bbbddd  Hzl  "ba"bbbbb  5.98  ±  0.23 
B10.A(2R)  kkkddb  Hzl  "ba"bbbbb  <1.30 [[ 
Nil  Hzl  '~ba"bbbbb  6.51  +- 0.06 
B10.A(5R)  bbbddd  C57BL/6  bbbbbb  <1.30 I[ 
Nil  C57BL/6  bbbbbb  5.51  ±  0.15 
*  Experimental  procedure is  described  in Materials and Methods. All  donors  were  immunized i.v.  with  2 x 104 
PFU of  attenuated virus.  Recipients  were injected  i.v.  with  2 x 104  of  virulent  virus  for  experiments 1  and  2 
and  with  5 x.  10  s  PFU for  experiment  3.  Viable  immune spleen  cell  doses,  given  i.v.  to  each  recipient,  were  5 × 
10  ~, 7 × 107,  and 15 × 10  ~  for  experiments 1,  2, and 3, respectively. 
S H-2  maps are  forK,  I-A,  I-B,  I-C,  S, andD regions  of  the  gene  complex. K region  of  Hzl is  designated "ba"  on 
the  basis  of  evidence cited  in  the  text. 
§ Results  are  expressed as  mean  log~o  virus  PFU per  organ  ± SE  of  the  mean  in  groups  of  four  mice.  The  limit  of 
detection  was 20  PFU/spleen (log~o  = 1.30). 
II  Significantly  less  than  control  groups  given  no  cells  (P < 0.01). 
which K- or D-region genes and/or their products interact with the viral genome 
or  its  products,  or  other  antigens  such  as  TNP,  to  produce  new  antigenic 
patterns which stimulate precursors of effecter T cells. It also provokes specula- 
tion as to the nature  of T-cell receptors for antigen,  and the scope of receptor 
dictionaries on various T-cell subsets. 
Further characterization of the nature of the genes in H-2K or H-2D regions is 
relevant to these questions.  We therefore investigated  B6.C-H-2  ba  (Hzl)  mice 
which bear a  mutation that  arose in the K  end of the H-2  b complex (21)  and 
has now been extensively characterized.  F1 hybrids of Hzl and another mutant 
of C57BL/6 reject C57BL/6 skin grafts (22),  thus suggesting strongly that each 
mutation involved the same single genetic element. Since C57BL/6 and Hzl and 
mice  also  give  reciprocal  mixed  lymphocyte  reactions  (MLR),  cell-mediated 
lympholysis (CML),  and  graft-versus-host reactions  (GVHR), it seems that  T 
cells recognize the  antigenic  pattern(s)  affected by the mutation,  and that K 
region  was  the  site  of change  (23,  24).  However,  the  structure  of antigenic 
determinants  recognized  by  B  cells  appear  qualitatively  unchanged  by the 
mutation on the basis of sound serological evidence  4 (21, 25). 
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The  data  in Table I  clearly show the  effect of the Hzl  mutation  on T-cell 
antiviral function in vivo. Immune T cells from B10.A(5R) mice, which reduced 
virus titers very efficiently in C57BL/6 mice because of shared K  region, did not 
have  a  significant  protective  effect in  Hzl  recipients,  whereas  T  cells  from 
B10.A(2R) mice operated efficiently in Hzl recipients because of  D-region homol- 
ogy.  These  results  therefore  suggest that  the  antigenic  patterns  induced  by 
ectromelia  infection,  which are recognized by effector T  cells,  do not directly 
involve serologically-defined H-2 antigenic determinants.  Instead, they seem to 
be controlled partly  by a  single genetic element responsible for alloantigenic 
patterns recognized by T cells in such reactions as MLR, CML, GVHR, and graft 
rejection  (23,  24).  What  is the  nature  of this  genetic  element?  Is it  a  single 
cistron coding for a polypeptide, as the conventional view of the complementa- 
tion results would suggest (22),  or is it a  more complex genetic unit,  perhaps 
concerned  with  the  saccharide  portion  of the H-2  glycoprotein  (26),  without 
precedent in the multigenic elements defined thus far in prokaryotic systems? 
Further characterization of the virus-induced antigenic patterns recognized by 
effector T cells may clarify this issue. 
Finally,  in  view of the  large  quantitative  effects of K-  or D-region  genes 
reported here, the rational exploitation in clinical medicine of T-cell-mediated 
mechanisms  against  infections and tumors,  perhaps  including  transfer  factor 
(27), could well be optimized by investigation of genetic regions analogous to K, 
D, and I  in the HLA complex. 
Summary 
Cell transfer experiments using mice with recombinant H-2 haplotypes were 
used to map the H-2 regions which must be shared by ectromelia-immune T-cell 
donors and virus-infected recipients for transfer of virus clearance mechanisms 
in the spleen. K- or D-region genes were necessary and sufficient;/-region genes 
were not involved. The remainder of the mouse genome could be varied widely 
without impairing the efficacy ofT-cell antiviral function, provided either aK or 
a  D  region was shared  in  the  donor-recipient  combination.  A  mutation  in  a 
single genetic element of the K region of the H-2 complex abolished the antiviral 
effect of immune T-cell transfer in a donor-recipient combination which shared 
the K  end. 
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